期刊文献+

糖皮质激素联合噻托溴铵治疗哮喘-慢阻肺重叠综合征的临床观察 被引量:7

下载PDF
导出
摘要 目的:研究糖皮质激素联合噻托溴铵治疗哮喘-慢阻肺重叠综合征的临床效果。方法:2016年8月-2017年8月收治哮喘-慢阻肺重叠综合征患者104例,根据治疗方法的差异分为两组各52例。两组均进行常规治疗,对照组采用糖皮质激素吸入治疗,观察组采用糖皮质激素联合噻托溴铵治疗。比较两组临床效果、肺功能以及症状评分。结果:观察组治疗后临床总有效率、第1秒用力呼气量(FEV1)、最大肺活量(FVC)、第1秒用力呼气量与最大肺活量比值(FEV1/FVC)、呼出气一氧化氮(FeNO)浓度、慢性阻塞性肺疾病症状(CAT)评分、哮喘症状(ACT)评分均优于对照组,差异有统计学意义(P<0.05)。结论:采用糖皮质激素和噻托溴铵的联合治疗哮喘-慢阻肺重叠综合征效果较为理想,有助于患者临床症状和肺功能的改善。
作者 陈振华
出处 《中国社区医师》 2019年第23期18-19,共2页 Chinese Community Doctors
  • 相关文献

参考文献5

二级参考文献42

  • 1Zeki AA, Schivo M, Chan A, et al. The Asthma-COPD overlap syndrome: a common clinical problem in the elderly [J]. J Allergy (Cairo), 2011,2011:861-926.
  • 2Louie S, Zeki AA, Schivo M, et al. The asthma-chronic obstructive puhnonary disease overlap syndrome: pharmacotherapeutic considerations [J]. Expert Rev Clin Pharmacol, 2013,6(2) : 197-219.
  • 3Miravitlles M, Soler-Catalufla JJ, Calle M, et al. Spanish COPD Guidelines (GesEPOC) :Pharmacological treatment of stable COPD [J]. Aten Primaria,2012,44(7) :425-437.
  • 4Soler-Catalufla JJ, Cosio B, Izquierdo JL, et al. Consensus document on the overlap phenotype COPD-asthma in COPD [J]. Arch Bronconeumol, 2012,48(9) :331-337.
  • 5Koblizek V, Chlumsky J, Zindr V, et al. Chronic Obstructive Pulmonary Disease: Official diagnosis and treatment guidelines ofthe Czech Pneumological and Phthisiological Society; a novel phenotypic approach to COPD with patient-oriented care [J]. Biomcd Pap Med Fac Univ Palacky Olomouc Czech Repub, 2013,157(2) : 189-201.
  • 6GOLD Executive Committee. Global strategy for the diagnosis, mangement,and prevention of chronic obstructive pulmonary disease (Revised 2011).
  • 7Ai-Kassimi FA, Alhamad EH. Chronic obstructive pulmonary disease lost in translation: Why are the inhaled corticosteroids skeptics refusing to go [ J ] ? Ann Thorac Med, 2013,8 ( 1 ) : 8-13.
  • 8Marc Miravitlles.A new approach to grading and treating COPD based on clinical phenotypes:surmnary of the Spanish COPD guidelines (GesEPOC) [J]. Prim Care Respir J, 2013,22(1): 117-121.
  • 9Hizawa N. Pharmacogeneties of chronic obstructive pulmonary disease [J]. Pharmacogenomics, 2013,14(10) : 1215-1225.
  • 10Ohar JA, Donohue JF. Mono- and combination therapy of long- acting bronehodilators and inhaled eortieesteroids in advanced COPD [J]. Semin Respir Crit Care Med, 2010,31 (3) :321-333.

共引文献137

同被引文献60

二级引证文献34

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部